StreetInsider.com News Articles

Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth

Mon, 13 Jul 2026 13:02:00 -0400

HOUSTON, July 13, 2026 (GLOBE NEWSWIRE) -- Neutra Corp (OTC: NTRR), a company focused on health, wellness, and life sciences, today announced its forward-looking strategy for the third and fourth quarters of 2026, centered on deepening relationships with clinical trial sponsors and Contract Research Organizations (CROs). Neutra Corp has committed its full resources to the growth and expansion of Neutra Life Sciences, its wholly owned clinical research Site Management Organization (SMO) subsidiary, as the Company's primary strategic priority for the remainder of 2026 and beyond.

Since its formation, Neutra Life Sciences has built the infrastructure required to

Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth

Mon, 13 Jul 2026 13:02:00 -0400

Since its formation, Neutra Life Sciences has built the infrastructure required to

Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth

Mon, 13 Jul 2026 13:02:00 -0400

Since its formation, Neutra Life Sciences has built the infrastructure required to

Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth

Mon, 13 Jul 2026 13:02:00 -0400

Since its formation, Neutra Life Sciences has built the infrastructure required to

Neutra Life Sciences forms women's health JV, adds new trials

Mon, 29 Jun 2026 15:29:36 -0400

Neutra Corp (OTC: NTRR) announced that its subsidiary Neutra Life Sciences has executed a joint venture partnership with Women's Healthcare Center of Baytown, opening a new clinical research site in Baytown, Texas, focused on women's health and OB/GYN specialties.

The subsidiary, which launched in 2025 and operates as a clinical research Site Management Organization (SMO), also reported it was awarded new clinical trials in oncology, dermatology, pulmonology, and women's health. Neutra Life Sciences said it secured new contracts with new sponsors as well as additional contracts with existing sponsors.

"Growing into a multi-therapeutic site network was done with intention," said Sydney Jim,

Neutra Life Sciences forms women's health JV, adds new trials

Mon, 29 Jun 2026 15:29:36 -0400

"Growing into a multi-therapeutic site network was done with intention," said Sydney Jim,

Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio

Mon, 29 Jun 2026 15:29:00 -0400

HOUSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Neutra Corp (OTC: NTRR), a company focused on health, wellness, and life sciences, today announced a series of operational milestones at its wholly owned subsidiary, Neutra Life Sciences, a clinical research Site Management Organization (SMO). Following its 2025 launch and early-stage growth, Neutra Life Sciences has proven its operational excellence with multiple clinical trial. Since its formation, Neutra Life Sciences has built the operational infrastructure required to support a sustainable, scalable site network, including standardized site operating procedures, an expanding investigator base, and a consistent track record of regulatory-compliant trial execution.

Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio

Mon, 29 Jun 2026 15:29:00 -0400

Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio

Mon, 29 Jun 2026 15:29:00 -0400

Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio

Mon, 29 Jun 2026 15:29:00 -0400

Neutra Corp subsidiary adds clinical research site in Texas

Mon, 13 Oct 2025 07:09:51 -0400

Neutra Corp (OTC: NTRR) announced that its subsidiary Neutra Life Sciences has added MediNet Family Care Clinic to its clinical research network. The Internal Medicine/Family Medicine site is located near the border of Sugar Land and Houston, Texas.

The facility will support Phase II and III clinical trials focused on chronic conditions including hypertension, diabetes, and hyperlipidemia. The site is operated by a research team with experience in conducting clinical trials.

"This new partnership represents another important step in our long-term strategy to grow organically and provide sponsors and CROs with efficient, responsive, and high-performing research sites," said Sydney Jim, CEO of

Neutra Corp subsidiary adds clinical research site in Texas

Mon, 13 Oct 2025 07:09:51 -0400

Neutra Corp's Subsidiary, Neutra Life Sciences, Adds to Its Site Network With New Joint Venture Partnership in Family Medicine

Mon, 13 Oct 2025 07:09:00 -0400

HOUSTON, TX - October 13, 2025 (NEWMEDIAWIRE) - Neutra Corp (OTC: NTRR) is proud to announce that its wholly owned subsidiary, Neutra Life Sciences, has expanded its clinical research footprint by securing a new clinical trial site, MediNet Family Care Clinic, which specializes in Internal Medicine/Family Medicine. This strategic move aligns with the companys ongoing mission to grow its site management organization (SMO) and bring high-quality, community-based research opportunities to diverse patient populations.

Located in a high-traffic area near the border of Sugar Land and Houston, this Internal Medicine/Family Medicine site is led by an experienced research team with a

Neutra Corp's Subsidiary, Neutra Life Sciences, Adds to Its Site Network With New Joint Venture Partnership in Family Medicine

Mon, 13 Oct 2025 07:09:00 -0400

Located in a high-traffic area near the border of Sugar Land and Houston, this Internal Medicine/Family Medicine site is led by an experienced research team with a

Neutra Corp Launches Corporate Rebranding Initiative, Unveils New Logo, New Website, and Strengthens Focus on Life Sciences Through Its SMO

Mon, 25 Aug 2025 07:39:00 -0400

HOUSTON, TX - August 25, 2025 (NEWMEDIAWIRE) - Neutra Corp (OTC: NTRR) today announced the launch of its corporate rebranding initiative, marked by the unveiling of a new company logo, refreshed brand identity, and redesigned corporate website. This initiative reflects the companys renewed commitment to its life sciences strategy, positioning Neutra Corp firmly within the healthcare sector through its wholly owned subsidiary, Neutra Life Sciences.

The rebrand underscores Neutra Corps transformation from its legacy business ventures toward a clear focus on advancing healthcare innovation. Through Neutra Life Sciences, the company is building a strong foundation in clinical research and site

Neutra Corp Launches Corporate Rebranding Initiative, Unveils New Logo, New Website, and Strengthens Focus on Life Sciences Through Its SMO

Mon, 25 Aug 2025 07:39:00 -0400

Neutra Life Sciences adds joint ventures in podiatry, oncology and dermatology

Mon, 04 Aug 2025 08:39:58 -0400

Neutra Corp (OTC: NTRR) announced its subsidiary Neutra Life Sciences has secured joint venture partnerships with three medical practices across different specialties, according to a company statement.

The partnerships include Epic Foot & Ankle Centers for podiatry services, Aspire Hospital Cancer Centers for radiation oncology, and Radiant Dermatology & Aesthetics Clinic for dermatology services. These sites are entering the onboarding process as part of Neutra Life Sciences' site management organization operations.

The expansion adds to Neutra Life Sciences' multi-specialty platform for clinical research services. The company operates as a site management organization that supports contract research organizations and sponsors conducting clinical trials.

"Our

Neutra Life Sciences adds joint ventures in podiatry, oncology and dermatology

Mon, 04 Aug 2025 08:39:58 -0400

"Our

Neutra Corps Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships

Mon, 04 Aug 2025 08:39:00 -0400

HOUSTON, TX - August 4, 2025 (NEWMEDIAWIRE) - Neutra Corp (OTC: NTRR) is hitting its stride with the purposeful growth in the clinical research industry with Neutra Life Sciences. Since the successful launch of its Site Management Organization (SMO), Neutra Life Sciences has strategically positioned itself for significant growth in the latter part of 2025 and the beginning of 2026. Neutra Life Sciences has solidified its multi-specialty platform by securing another suite of Joint Venture Partnerships.

These new joint venture sites will be in the onboarding process:

Podiatry

Epic Foot & Ankle Centers (www.epicfootandankle.com)

Radiation Oncology

Aspire Hospital

Neutra Corps Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships

Mon, 04 Aug 2025 08:39:00 -0400

These new joint venture sites will be in the onboarding process:

Podiatry

Epic Foot & Ankle Centers (www.epicfootandankle.com)

Radiation Oncology

Aspire Hospital

Neutra Corp subsidiary adds three joint venture partnerships

Mon, 04 Aug 2025 08:30:35 -0400

Neutra Corp (OTC: NTRR) announced that its subsidiary Neutra Life Sciences has secured three new joint venture partnerships to expand its clinical research operations.

The partnerships include Epic Foot & Ankle Centers for podiatry research, Aspire Hospital Cancer Centers for radiation oncology studies, and Radiant Dermatology & Aesthetics Clinic for dermatology trials. These sites are entering the onboarding process, according to the company's statement.

Neutra Life Sciences operates as a Site Management Organization that conducts clinical trials across multiple medical specialties. The company launched this division as part of its expansion into the clinical research industry.

"Our growth reflects the increasing demand for

Neutra Corp subsidiary adds three joint venture partnerships

Mon, 04 Aug 2025 08:30:35 -0400

Neutra Corp (OTC: NTRR) announced that its subsidiary Neutra Life Sciences has secured three new joint venture partnerships to expand its clinical research operations.

"Our growth reflects the increasing demand for

Neutra Corp's Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships

Mon, 04 Aug 2025 08:30:00 -0400

These new joint venture sites will be in the onboarding process:

Podiatry

Epic Foot & Ankle Centers (www.epicfootandankle.com)

Radiation Oncology

Aspire Hospital

Neutra Corp's Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships

Mon, 04 Aug 2025 08:30:00 -0400

These new joint venture sites will be in the onboarding process:

Podiatry

Epic Foot & Ankle Centers (www.epicfootandankle.com)

Radiation Oncology

Aspire Hospital

Neutra Corp Reports Breakthrough First Quarter Following Launch of Its New Clinical Research Network

Mon, 30 Jun 2025 07:39:00 -0400

HOUSTON, TX - June 30, 2025 (NEWMEDIAWIRE) - Neutra Life Sciences, a newly launched Site Management Organization (SMO) and wholly owned subsidiary of Neutra Corp (OTC: NTRR), is proud to announce a strong and promising start to operations in Q1 2025. Founded on the success of a pilot program personally funded by its CEO in 2024, the company has already achieved positive operational cash flow in under six months, signaling a strong market position and operational efficiency from the outset.

With a mission to become the leading SMO in the clinical research industry, Neutra Life Sciences is focused on building